Stocks › ELAN
Elanco Animal Health Inc
ELAN·NYSE·
United States·USD
$25.74
-0.55 (-2.09%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
ELAN
Elanco Animal Health Inc · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
ELANS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of ELAN by members of U.S. Congress · 135 on record · 4 in the last 12 months
Whale Activity
Position changes in ELAN reported for 2026-09-30 by 598 institutional filers
- Increased192
- New76
- Held75
- Decreased160
- Closed64
- No prior filing31
| Filer | Shares | Value | Change |
|---|---|---|---|
| FMR LLC | 66.5M | $1.49B | increased |
| DODGE & COX | 61.4M | $1.38B | decreased |
| BlackRock, Inc. | 49.3M | $1.10B | increased |
| PRIMECAP MANAGEMENT CO/CA/ | 45.4M | $1.02B | decreased |
| DIMENSIONAL FUND ADVISORS LP | 25.1M | $561.3M | decreased |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 23.1M | $517.0M | increased |
| VANGUARD CAPITAL MANAGEMENT LLC | 22.5M | $504.7M | decreased |
| T. Rowe Price Investment Management, Inc. | 22.4M | $501.1M | decreased |
| STATE STREET CORP | 16.3M | $364.6M | increased |
| Black Creek Investment Management Inc. | 13.4M | $299.9M | increased |
| MARSHALL WACE, LLP | 10.0M | $224.4M | increased |
| GEODE CAPITAL MANAGEMENT, LLC | 9.3M | $209.2M | decreased |
Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.
Insider Trading
Net shares bought (+) or sold (−) on the open market by ELAN insiders, by quarter · Form 4
Recent Insider Transactions
576 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Bettington Timothy JSEE REMARKS | Sale | −4,350 | $23.00 | $100K | Oct 15, 2026 | Form 4 ↗ |
| Kurzius Lawrence ErikDirector | Purchase | +40.0K | $23.40 | $936K | Aug 20, 2026 | Form 4 ↗ |
| O'Neill ShivGC AND CORP SEC | Purchase | +3,998 | $23.58 | $94K | Aug 18, 2026 | Form 4 ↗ |
| Harrington Michael JDirector | Purchase | +5,000 | $21.82 | $109K | Aug 12, 2026 | Form 4 ↗ |
| VanHimbergen Robert MEVP and CFO | Purchase | +4,200 | $23.08 | $97K | Aug 7, 2026 | Form 4 ↗ |
| Herendeen PaulDirector | Purchase | +10.0K | $23.69 | $237K | Aug 7, 2026 | Form 4 ↗ |
| VanHimbergen Robert MEVP and CFO | Tax withholding | −15.3K | $24.64 | $378K | Jul 7, 2026 | Form 4 ↗ |
| Ma StaceyDirector | Grant / award | +12.2K | $0.00 | $0 | May 21, 2026 | Form 4 ↗ |
| Ma StaceyDirector | Grant / award | +4,678 | $0.00 | $0 | May 21, 2026 | Form 4 ↗ |
| Anand Kapila KDirector | Grant / award | +12.2K | $0.00 | $0 | May 21, 2026 | Form 4 ↗ |
| Anand Kapila KDirector | Grant / award | +4,678 | $0.00 | $0 | May 21, 2026 | Form 4 ↗ |
| Harrington Michael JDirector | Grant / award | +12.2K | $0.00 | $0 | May 21, 2026 | Form 4 ↗ |
| Harrington Michael JDirector | Grant / award | +4,678 | $0.00 | $0 | May 21, 2026 | Form 4 ↗ |
| McDonald Kirk PDirector | Grant / award | +12.2K | $0.00 | $0 | May 21, 2026 | Form 4 ↗ |
| McDonald Kirk PDirector | Grant / award | +4,678 | $0.00 | $0 | May 21, 2026 | Form 4 ↗ |
| Kochevar Deborah TurnerDirector | Grant / award | +4,678 | $0.00 | $0 | May 21, 2026 | Form 4 ↗ |
| Herendeen PaulDirector | Grant / award | +12.2K | $0.00 | $0 | May 21, 2026 | Form 4 ↗ |
| Herendeen PaulDirector | Grant / award | +4,678 | $0.00 | $0 | May 21, 2026 | Form 4 ↗ |
| Kurzius Lawrence ErikDirector | Grant / award | +12.2K | $0.00 | $0 | May 21, 2026 | Form 4 ↗ |
| Kurzius Lawrence ErikDirector | Grant / award | +4,678 | $0.00 | $0 | May 21, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding ELAN · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| Dodge & Cox Stock Fund Dodge & Cox Funds | 43.1M | $1.06B | 0.90% | Jun 30, 2026 |
| VANGUARD PRIMECAP FUND VANGUARD CHESTER FUNDS | 17.8M | $436.9M | 0.45% | Jun 30, 2026 |
| iShares Core S&P Mid-Cap ETF iShares Trust | 17.1M | $420.6M | 0.34% | Jun 30, 2026 |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 15.9M | $390.6M | 0.02% | Jun 30, 2026 |
| VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS | 11.4M | $281.7M | 0.15% | Jun 30, 2026 |
| VANGUARD CAPITAL OPPORTUNITY FUND VANGUARD HORIZON FUNDS | 10.2M | $250.1M | 0.76% | Jun 30, 2026 |
| Strategic Advisers Fidelity U.S. Total Stock Fund Fidelity Rutland Square Trust II | 10.3M | $247.3M | 0.09% | Aug 31, 2026 |
| T. Rowe Price Mid-Cap Growth Fund, Inc. | 9.6M | $235.1M | 1.02% | Jun 30, 2026 |
| Fidelity Low-Priced Stock Fund Fidelity Puritan Trust | 7.3M | $192.9M | 0.78% | Jul 31, 2026 |
| VANGUARD SMALL-CAP VALUE INDEX FUND VANGUARD INDEX FUNDS | 7.3M | $178.6M | 0.26% | Jun 30, 2026 |
Mutual funds and ETFs whose N-PORT filings list ELAN's shares (CUSIP 28414H103), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
- T. Rowe Price Investment Management, Inc.SCHEDULE 13G/A · passive (13G) · 22.4M shares4.5%
Nov 16, 2026 · ↗ - Dodge & CoxSCHEDULE 13G/A · passive (13G) · 61.4M shares12.3%
Nov 12, 2026 · ↗ - Abigail P. JohnsonSCHEDULE 13G/A · passive (13G) · 66.2M shares13.3%
Nov 5, 2026 · ↗ - FMR LLCSCHEDULE 13G/A · passive (13G) · 66.2M shares13.3%
Nov 5, 2026 · ↗ - Dimensional Fund Advisors LPSCHEDULE 13G · passive (13G) · 25.4M shares5.1%
Jul 14, 2026 · ↗ - Dodge & CoxSCHEDULE 13G/A · passive (13G) · 68.9M shares13.9%
May 14, 2026 · ↗ - PRIMECAP MANAGEMENT CO/CA/SCHEDULE 13G/A · passive (13G) · 45.8M shares9.2%
May 13, 2026 · ↗
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming elanco animal health as client
- STUMPTOWN STRATEGIESELANCO ANIMAL HEALTH · 2026 Q3 · TRD, ANI, ENV, BUD$20K
Filing ↗ - BOSE PUBLIC AFFAIRS GROUPELANCO ANIMAL HEALTH INCORPORATED · 2026 Q3 · AGR, ANI—
Filing ↗ - ELANCO ANIMAL HEALTH INCORPORATEDELANCO ANIMAL HEALTH INCORPORATED · 2026 Q3 · AGR, TRD, ANI, ENV$230K
Filing ↗ - BROWNSTEIN HYATT FARBER SCHRECK, LLPELANCO ANIMAL HEALTH · 2026 Q3 · PHA, TAR$140K
Filing ↗ - STUMPTOWN STRATEGIESELANCO ANIMAL HEALTH · 2026 Q3 · AGR, TAR, ANI—
Filing ↗
Government Contracts
Federal awards to Elanco Animal Health Inc · USAspending
No federal contract awards found for Elanco Animal Health Inc.
U.S. Patents
Recent USPTO applications naming Elanco Animal Health Inc
No USPTO patent applications found for Elanco Animal Health Inc.
Annual Financials
From ELAN's 10-K filings · XBRL
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $4.71B | $4.44B | $4.42B | $4.41B | $4.76B |
| Net income | -$232.0M | $338.0M | -$1.23B | -$78.0M | -$483.0M |
| Diluted EPS | -$0.47 | $0.68 | -$2.50 | -$0.16 | -$0.99 |
| Operating cash flow | $560.0M | $541.0M | $271.0M | $452.0M | $483.0M |
| Cash and equivalents | $545.0M | $468.0M | $352.0M | $345.0M | $638.0M |
| Total assets | $13.36B | $12.61B | $14.36B | $15.49B | $16.48B |
| Total liabilities | $6.81B | $6.52B | $8.14B | $8.20B | $8.97B |
| Shareholders' equity | $6.55B | $6.10B | $6.22B | $7.29B | $7.51B |
As Elanco Animal Health Inc tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 24, 2026 ↗
Stock Splits
Every split and reverse split in the price history
No stock splits in ELAN's price history.
About Elanco Animal Health Inc
From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersINDIANAPOLIS, IN
SEC CIK0001739104 ↗


